HILD

  • Research type

    Research Study

  • Full title

    Harnessing Immunity for Lung Cancer Early Detection

  • IRAS ID

    360498

  • Contact name

    Sean Knight

  • Contact email

    sean.knight@manchester.ac.uk

  • Sponsor organisation

    University of Manchester

  • Duration of Study in the UK

    1 years, 11 months, 30 days

  • Research summary

    New tests that can diagnose lung cancer early are urgently needed to stop people being diagnosed when it is too late for a cure. We have recently found that immune cells are different in people with lung cancer. This study will check whether these differences are strong enough to identify people with lung cancer who were not part of the original study. People with lung cancer will be asked to donate a blood and nose swab alongside their routine clinical care. They will be approached at times when they are waiting for investigations and not on days when bad news is being delivered. In addition, people without lung cancer who are attending lung health checks will also be asked to donate a blood sample and nasal swab. All participants will have the option of donating samples on the day of approach or on another day of their choosing if it is not convenient at the time they are approached. There will only be one research visit for each participant (either they donate samples at the time of approach or at another time, but not both). We will analyse these populations to check whether we can accurately identify people with lung cancer from the patterns in their immune system. If this works, we could develop new tests for lung cancer screening.

  • REC name

    East Midlands - Nottingham 1 Research Ethics Committee

  • REC reference

    25/EM/0238

  • Date of REC Opinion

    30 Oct 2025

  • REC opinion

    Further Information Favourable Opinion